Off-Label Use of Dexmedetomidine for the Treatment of Delirium in the Intensive Care Unit
- PMID: 27757003
- PMCID: PMC5047002
Off-Label Use of Dexmedetomidine for the Treatment of Delirium in the Intensive Care Unit
Abstract
Objective: Evaluate recent clinical studies involving the use of dexmedetomidine (DEX) infusion for the treatment of delirium in the intensive care unit (ICU).
Methods: A literature search was conducted to identify peer-reviewed articles in MEDLINE (1966-June 2016) using the terms sedation, analgesic, dexmedetomidine, delirium, and critically ill adult patients.
Results: Two studies in the ICU setting reported the potential benefits of DEX for managing agitation during weaning from mechanical ventilation. One pilot study and a clinical trial reported the use of DEX in the treatment of ICU delirium.
Conclusion: Further studies are required to evaluate the use of DEX treatment in critically ill patients presenting with delirium.
Keywords: critically ill patients; delirium; dexmedetomidine.
Similar articles
-
Pain, fentanyl consumption, and delirium in adolescents after scoliosis surgery: dexmedetomidine vs midazolam.Paediatr Anaesth. 2013 May;23(5):446-52. doi: 10.1111/pan.12128. Epub 2013 Feb 28. Paediatr Anaesth. 2013. PMID: 23448434 Clinical Trial.
-
Prolonged sedation in critically ill children: is dexmedetomidine a safe option for younger age? An off-label experience.Minerva Anestesiol. 2019 Feb;85(2):164-172. doi: 10.23736/S0375-9393.18.13062-8. Epub 2018 Oct 30. Minerva Anestesiol. 2019. PMID: 30394067
-
Dexmedetomidine reduces the risk of delirium, agitation and confusion in critically Ill patients: a meta-analysis of randomized controlled trials.J Cardiothorac Vasc Anesth. 2014 Dec;28(6):1459-66. doi: 10.1053/j.jvca.2014.03.010. Epub 2014 Jul 14. J Cardiothorac Vasc Anesth. 2014. PMID: 25034724
-
Dexmedetomidine: a review of its use for the management of pain, agitation, and delirium in the intensive care unit.Curr Pharm Des. 2013;19(22):4003-13. doi: 10.2174/1381612811319220009. Curr Pharm Des. 2013. PMID: 23228319 Review.
-
Role of dexmedetomidine for the prevention and treatment of delirium in intensive care unit patients.Ann Pharmacother. 2013 Jun;47(6):869-76. doi: 10.1345/aph.1AR708. Ann Pharmacother. 2013. PMID: 23719785 Review.
Cited by
-
Cholinesterase inhibitors for the treatment of delirium in non-ICU settings.Cochrane Database Syst Rev. 2018 Jun 28;6(6):CD012494. doi: 10.1002/14651858.CD012494.pub2. Cochrane Database Syst Rev. 2018. PMID: 29952000 Free PMC article.
References
-
- Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41:263–306. - PubMed
-
- Dubois MJ, Bergeron N, Dumont M, et al. Delirium in an intensive care unit: a study of risk factors. Intensive Care Med. 2001;27:1297–1304. - PubMed
-
- Pandharipande PP, Shintani A, Perterson J, et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology. 2006;104:21–26. - PubMed
-
- Ely EW, Shintani A, Truman B. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004;291:1753–1762. - PubMed
LinkOut - more resources
Full Text Sources